García-Basteiro, Alberto L.Jenkins, Helen E.Rangaka, Moleboleng2019-07-152019-07-152019-07-041473-3099https://hdl.handle.net/2445/137217In the past 10 years, there has been renewed interest in the early phases of the natural history of tuberculosis.1 Estimates suggest that around 25% of the world's population could have latent tuberculosis infection,2 5–10% of whom will develop active disease during their lifetime3 (10% annually among people with HIV).4 Failure to implement effective tuberculosis control measures to manage latent infection threatens elimination goals.2 p.application/pdfengcc by-nc-nd (c) García-Basteiro et al., 2019http://creativecommons.org/licenses/by-nc-nd/3.0/es/TuberculosiResistència als medicamentsTuberculosisDrug resistanceinfo:eu-repo/semantics/article2019-07-12info:eu-repo/semantics/openAccess